NantHealth shares soar 36% in market debut

Shares of NantHealth Inc. were up 36% in the biotech company’s market debut on the Nasdaq Thursday. Shares were trading around $19 in midday trade, above the company’s $14 issue price. The company sold 6.5 million shares to raise $91 million. Jefferies LLC and Cowen and Company, LLC acted as the lead underwriters.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Leave a Reply